Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 04, 2023 16:22 ET | Source: Nanobiotix S.A.

Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc.

Aggregate gross proceeds of approximately €50.9 million (equivalent to approximately $53.8 million) received by NANOBIOTIX has increased to approximately €55.5 million (equivalent to approximately...
December 04, 2023 16:16 ET | Source: Nanobiotix S.A.

Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc.

Aggregate gross proceeds of approximately €50.9 million (equivalent to approximately $53.8 million) received by NANOBIOTIX has increased to approximately €55.5 million (equivalent to approximately...
November 16, 2023 09:00 ET | Source: JenaValve Technology, Inc.

JenaValve Announces Partnership with the American Society of Echocardiography (ASE) to Advance Detection and Diagnosis of Aortic Regurgitation

IRVINE, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that it will join the...
November 06, 2023 02:00 ET | Source: Nanobiotix S.A.

NANOBIOTIX Announces the Availability of a Prospectus in Connection with Capital Increases Raising Total Gross Proceeds of Approximately $50M and the Exercise by the Underwriters of the Over-Allotment Option for an Additional Amount of Approximately $3.6M

PARIS and CAMBRIDGE, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “Nanobiotix” or the “Company”), a late-clinical stage biotechnology company pioneering...
November 02, 2023 10:49 ET | Source: Nanobiotix S.A.

NANOBIOTIX Announces Pricing of a Capital Increase Raising Total Gross Proceeds of $55M

PARIS and CAMBRIDGE, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “Nanobiotix” or the “Company”), a late-clinical stage biotechnology company pioneering...
October 24, 2023 17:00 ET | Source: JenaValve Technology, Inc.

JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy Endpoints

IRVINE, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced results from the...
October 17, 2023 00:30 ET | Source: Future Market Insights Global and Consulting Pvt. Ltd.

Qatar Cement Market Poised for Remarkable Growth, with Projected Valuation of US$ 1,550.9 Million by 2032 | Future Market Insights, Inc.

NEWARK, Del, Oct. 17, 2023 (GLOBE NEWSWIRE) -- According to a research study by Future Market Insights, the Qatar cement market is poised for significant growth, with demand projected to reach a...
September 19, 2023 09:00 ET | Source: JenaValve Technology, Inc.

JenaValve Announces ALIGN-AR Pivotal Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2023

IRVINE, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that data from the...
September 14, 2023 09:00 ET | Source: JenaValve Technology, Inc.

JenaValve Appoints Shlomi Nachman to Board of Directors

IRVINE, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR) systems, today announced...
August 31, 2023 07:28 ET | Source: Research Nester

Contactless Biometrics Technology Market revenue to hit USD 50 Billion by 2035, says Research Nester

New York, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The global Contactless Biometrics Technology market size is slated to expand at ~ 20 % CAGR between 2023 and 2035. The market is poised to garner a...